Member Info for Davemcmanus

They are funded for the rest of year at the very least.

Porky you're a right desperate prize. They need to issue data to regain market's confidence, no director or Merck share purchase is going to restore confidence. If the data is good is the buys will come in themselves. The current drop is due to lost confidence largely as they haven't delievered the news they said they would despite changing guidance multiple times.

"The Options awarded today vest in equal parts annually over a period of four years, beginning on 1 June 2022, save for John Doyle where vesting starts from 3 January 2023, and are exercisable over a period of 10 years from the date of grant."

So my reading of that is the 7.5m options could be exercised from 17th November, the second tranche of 7.2m options have a date from 1st June 2022 as you say."

Coldbrew you are reading it wrong. "Option granted on x day" just means the day things were finalised..i.e the day decision was made and paperwork completed etc....it does not mean exercisable from the said date. All options have a vest date from 1st June except for Doyle, whose options vest in Jan 2023. They therefore cannot exercise any optiobs before the vest date.

Porky you are the real prize d*** everyone knows you're full of porky pies with your imaginary consistent buying. You are desperate if you goto the extent of lieing about the options being made up to take liveria's holding lol. Laughable. Everyone knows the options will be new shares that are issued, so why did you feel the beed to.lie? Desperation at it's finest.

"why didn't or why haven't they exercised a single one of the 7,520,152 share options that were apparently granted to them on 17th December, at 52p? They're not subject to any kind of qualifying period, they were good to go immediately - at least by my reading of the RNS - and the share price briefly drifted higher than that."

Coldbrew you are wrong, read the RNS. They cannot exercise these options immediately, they have a vest date from 1st Jun 2022 so they can't buy these options now even if they know newsflow will be poditive in Q1.

"It's interesting that the additional options issued at 53.6p account for 8% which means when the BOD make the move to buy the shares they can effectively take out SO position."

Porky stop making up Porky pies. Anyone with sone common sense knows the options will be NEW shares issued, not from existing shares on the market. Cut out the cr** , you're getting very boring and and sounding desperate.

" it's utter madness to me for anyone to suggest the Board should hold fire on releasing good news until Oliveira's done, and unless the Board get on the front foot soon they risk this share imploding further with loyal PIs selling up also."

Well said Coldbrew couldn't have said better myself. People want the perfect market conditions for news, which sadly is unrealistic and impossible. There will aleays be external factors at play such as general market, sellers, liquidity which would mean you'd never get a RNS!!!

If anything they need to release some news now to clear the seller out and get some investor confidence back.

"Dave Mmacanus, please do a declaration of interest! How much does your boss pay you per post"

Michael perhaps you can tell us how much you're being paid to put a positive spin on things. Please explain how a 70% drop in shareprice in under 12 months is a positive,management's failure to bring in instititions or take on Oliveria's shares which are being dumped in the open market, guidances missed not once but multiple times amongst others. It is clear you are day trader scalping for your quick 10% with your buddy Sang.

"The guys that are in charge are scientists trying to run a big business with absolutely no business acumen whatever and this is underlying problem to why the SP is where it is"

Duncan is not a scientists hence he is tge CEO and should be managing the business side of things, but to date he has been useless. Alex is the scientist.

Michael perhaps you'd like to contribute about the science? Really what else do you wsnt people to say in the absence of news? Everything has already been said about the science, and there isn't anything to discuss until there is some material news you clown. Otherwise you can carry on speculating and dreaming like a broken record about the updates due and and a big takeover.

For your information i understand the business here very well I have a big holding here, however what I didn't exprct was this shoddy behaviour from management. The share price is down is 70% down from NASDAQ debut, yet rather than adddress this they instead have employed consultants to bring their salaries in line with Nasdaq peers? They also delayed news as to not affect their options.

As for your comment about Sang, you must be part of his little P&D operation, as anyone on this board knows he changes his view consustently according to his trading position. You must be another clown doing the same thing.

"Meanwhile, i am the only one relaxed here Jeeze, give Duncan a bloody break. So a few staff options? so what. Lets see the SP back above the placing rate and the position starts to look better."

Porky some of these guys have been here 2 years and spent the whole 2021 waiting on news that never arrived, so the frustration is understandable. It's easy for you to tell them to chill out as you've not bought in long ago, and already had a succesful trade. Show them some courtsey.

"It's the whole of twitter" citing one tweet. Ridiculous"

Seems like you don't know how to use Twitter :). Suggest you put #DDDD in the search and see for yourself. It's impossible to post every f**** tweet on here

"SO selling up has crushed the SP since August. Coupled with biotech sector that's been in the doldrums all year, any significant news (esp. MRx0518) would've fallen on deaf ears & SO would've just sold into anyway"

That's irrelevant they should still release news regardless of a big seller lurking. There will always be some external fsvtors in play, doesn't mean companies can hold back news indefinently. If anything it was was a positive as it would have meant the good news would have bought in the volume to clear out SO back in the summer, and he would have been a distant memory. As it stands there has been nothing from the mangement to draw those buyers in to take SO out.

"For my part, I'm happy to view it as insiders increasing their stake in the business which is as strong a buy signal as you could possibly hope for. "
They haven't increased their stake or bought or anything, they have the OPTION to buy for 4 years at 53p. If within 4 years the SP is 10p they just walkaway, however if it's £10 they can buy those options for 53p and sell them immediately fir a 1900% profit. Not exactly aligned to investors is it, who have to risk capital upfront.

Well articulated post Coldbrew, and I made the same point about MRX0518 open label trials as the data seems to have been witheld from the market for reasons unknown.

There would have been something to report in Oncology, as the last update was in Feburary 2020 so rven working on a 6 monthly interval, they would have had something to report on in the Summer but they chose not to. Before those with rose tinted glasses on suggest there was nothing to report, if in 6 months you have nothing to report on an open label clinical trial then that suggests your treatment isn't working and is worthless as it's not having any effect. Clearly not the case!! The timing of the options, the very late release of Asthma data into Xmas shutdown and failing to report on all the catalyst by year end is all a bit suspect.

Rusty Pete, it's not just me that shares this view, it's the whole of Twitter. You obviously wear rose tinted glasses, or just a 10% ramper. See below a well articulated later that summarises the situation perfectly

https://twitter.com/Stockonomist/status/1478647544527917063?s=20

Seriously go do some research you obnoxious fool.

The investor conference means sod all at this stage, they need to put out some good clinical data that is well overdue. Giving themselves cheap options on a depressed shareprice, reviewing remuneration packages whilst witholding data is a cheap shot.

*violin

You still need a violinto accompany every post from crl123. No one cares about your losses on other shares, this a DDDD board. Post about DDDD or stay quiet. Ever since i've been here for the past few months, all you ever post about is your losses on AIM, poor performance of your other shares, your health. Ffs get a grip or see a phsycologist.

Prickymatters what happrned to the £374M contract you kept ramping at ODX, along with your continous topups of 10s of thousands pounds. Such a pathetic ramper you are Hunter. Remember your post below only a few weeks ago telling everyone ODX had bagged the £37=m contract

"Flashy, Flashy, Flashy. Umm. It does mean that this is the DHSC contract. Shall I explain? 1. OG are one of only 3 tests currently approved for EUA for public health. They are exempted from UKCTA regulations for this context. ODX were waiting for government to decide on which test they should manufacture fort the DHSC- talking to 3 approved firms. This photo shows we are manufacturing for OG. For the DHSC contract. Up to £374 million.
Helpful? Lol."
"